A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. (2018)

First Author: Fraser H
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2018.01.006

PubMed Identifier: 29552576

Publication URI: http://europepmc.org/abstract/MED/29552576

Type: Journal Article/Review

Volume: 8

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501